Statin Use and Cancer Incidence in Patients with Type 2 Diabetes Mellitus: A Network Meta-Analysis

Table 2

Ranking curve (SUCRA) value of per intervention.

Treatment	SUCRA	PrBest	Mean rank
Nonstatin	1.1	0.0	7.9
Simvastatin	61.2	6.6	3.7
Atorvastatin	61.9	20.3	3.7
Pravastatin	51.4	10.4	4.4
Fluvastatin	65.6	24.8	3.4
Lovastatin	26.5	0.3	6.1
Rosuvastatin	80.1	35.0	2.4
Pitavastatin	52.2	2.6	4.3

PrBest: the probability of becoming the best treatment; mean rank: the average ranking of treatment measures; SUCRA: surface under the cumulative.